These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10963610)

  • 1. Vaccines against intracellular infections requiring cellular immunity.
    Seder RA; Hill AV
    Nature; 2000 Aug; 406(6797):793-8. PubMed ID: 10963610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating humoral immune memory following infection or vaccination.
    Randall KL
    Expert Rev Vaccines; 2010 Sep; 9(9):1083-93. PubMed ID: 20822350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines.
    van Rooij EM; Moonen-Leusen HW; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
    Vaccine; 2006 Feb; 24(9):1264-73. PubMed ID: 16289276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines: correlates of vaccine-induced immunity.
    Plotkin SA
    Clin Infect Dis; 2008 Aug; 47(3):401-9. PubMed ID: 18558875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccines: immunology, application, and optimization*.
    Gurunathan S; Klinman DM; Seder RA
    Annu Rev Immunol; 2000; 18():927-74. PubMed ID: 10837079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune markers and correlates of protection for vaccine induced immune responses.
    Thakur A; Pedersen LE; Jungersen G
    Vaccine; 2012 Jul; 30(33):4907-20. PubMed ID: 22658928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal vaccines: the promise and the challenge.
    Neutra MR; Kozlowski PA
    Nat Rev Immunol; 2006 Feb; 6(2):148-58. PubMed ID: 16491139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses.
    Newman MJ
    Curr Opin Investig Drugs; 2002 Mar; 3(3):374-8. PubMed ID: 12054082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination vaccines: synergistic simultaneous induction of antibody and T-cell immunity.
    Moore AC; Hutchings CL
    Expert Rev Vaccines; 2007 Feb; 6(1):111-21. PubMed ID: 17280483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From plasmids to protection: a review of DNA vaccines against infectious diseases.
    Laddy DJ; Weiner DB
    Int Rev Immunol; 2006; 25(3-4):99-123. PubMed ID: 16818367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.
    Igietseme JU; Eko FO; He Q; Black CM
    Expert Rev Vaccines; 2004 Feb; 3(1):23-34. PubMed ID: 14761241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
    White A
    Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
    Innes EA; Vermeulen AN
    Parasitology; 2006; 133 Suppl():S145-68. PubMed ID: 17274844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.
    Pantaleo G; Koup RA
    Nat Med; 2004 Aug; 10(8):806-10. PubMed ID: 15286782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccination against pseudorabies virus and bovine respiratory syncytial virus infections of young animals in the face of maternally derived immunity.
    Hamers C; Juillard V; Fischer L
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S35-41. PubMed ID: 17553517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immune responses induced by BHV-1: rational vaccine design.
    van Drunen Littel-van den Hurk S
    Expert Rev Vaccines; 2007 Jun; 6(3):369-80. PubMed ID: 17542752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?
    Belyakov IM; Ahlers JD
    J Immunol; 2009 Dec; 183(11):6883-92. PubMed ID: 19923474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.